Clinical trial
Evaluation of the Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Patients With Irritable Bowel Syndrome and Healthy Subjects
NCT03366389 is registered in ClinicalTrials.gov with Amir Abbasnezhad as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Serum Levels of Apelin, Chemerin and Adiponectin Adipokines in Patients With Irritable Bowel Syndrome and Healthy Subjects
- Lead sponsor
- Amir Abbasnezhad
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 7, 2017
- Completion date
- October 20, 2017
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.